EQUITY MARKET (9th Nov 2026)

FII/FPI & DII trading activity on NSE, BSE and MSEI in Capital Market Segment: 08th Nov 2026

As of 10:11 (IST)

NSE ADVANCE/DECLINE:

As of 10:12 (IST)

NIFTY INDEX DAILY REPORT

Navigating a choppy session, the headline Nifty 50 staged a solid intraday recovery to finish marginally in the green at 25,044.65, gaining 58.25 points from the prior close of 24,986.40. The index kicked off the day on an optimistic footing at 25,076.40 and quickly peaked at an intraday high of 25,084.05, only to succumb to intense mid-day profit booking that pulled it down to a trough of 24,838.75. Aggressive value buying emerged in the final hours, allowing the index to decisively reclaim the crucial 25,000 threshold and signaling healthy demand at lower levels alongside strong technical base-building.tra

Maintaining a constructive tone, Bank Nifty sustained comfortable territory above the psychological 59,100 mark at 59,744 to log notable gains. Starting the week on an upbeat note at 59,219.95, the sectoral gauge briefly receded to an intraday base of 58,877.85 before swift accumulation sparked an upside rally of more than 540 points from the prior close, taking it to a high of 59,393.45. Underlying market internals stayed largely positive, driven by strong upward traction in frontline banking majors, most notably SBI, HDFC Bank, and ICICI Bank, which easily counterbalanced isolated pockets of weakness seen in Kotak Mahindra Bank and Axis Bank.

Nifty Pharma index took center stage amid robust defensive accumulation across healthcare names. Following a positive start, steady buying interest propelled the sectoral basket roughly 1.6% higher into the 28,880–28,900 range, well above the preceding close of 28,427.75. The intraday trend remained emphatically positive, with the index surging to an intraday peak of 29,224.85 after finding firm support near its session low of 28,351.60. Market participation within the sector was comprehensively bullish, clocking 17 gainers among its 20 components as strong rallies in generic, API, and CDMO players, including Divi’s Laboratories, Laurus Labs, Gland Pharma, and Sai Life Sciences, readily absorbed marginal profit-taking in heavyweight Sun Pharma.

Demonstrating solid resilience, the Nifty Realty index finished the session on a positive note, mounting a consistent intraday rebound following early softness. The sectoral gauge kicked off the week at 891.60 and momentarily dropped to a trough of 882.60 under initial profit-taking. Strong demand at lower price bands quickly countered the pullback, propelling the index to a session high of 897.85 before it ended near the top at 897.70, securing an advance of 6.85 points (+0.77%) over its prior close of 890.85. The upward trajectory signaled orderly base-building and sustained accumulation among major real estate players, reinforced by steady housing uptake and broader market strength.

NIFTY DAILY CHART

The Nifty50 traded with  positive bias  and managed to trade above the 24,800 mark with a gain of 0.23%. RSI continued to move in the oversold zone and went to the high of 77.88, indicating the index might see a breather and may plunge. But only sustained trading above the 25,100 level could push the index to 25.250. Fall below the falls below the mark of 24,800 could make the index weaker towards the mark 24,600.

Post Market Update:

FII/FPI & DII trading activity on NSE, BSE and MSEI in Capital Market Segment: 09th Nov 2026

Disclaimer:

Investment in securities markets is subject to market risks. Please read all related documents carefully before investing. (Our SEBI Reg. No. INH000010335)

AI Usage Disclosure: Artificial Intelligence (AI) tools were utilized exclusively for document formatting, structural layout, and presentation refinement.
All underlying research, financial analysis, forecasts, and investment recommendations are fully independent and conducted solely by the analyst(s).

For Full Disclaimer: Click Here